CROSS-PROTECTION BY B-SUBUNIT WHOLE CELL CHOLERA VACCINE AGAINST DIARRHEA ASSOCIATED WITH HEAT-LABILE TOXIN PRODUCING ENTERO-TOXIGENIC ESCHERICHIA-COLI - RESULTS OF A LARGE-SCALE FIELD TRIAL
CROSS-PROTECTION BY B-SUBUNIT WHOLE CELL CHOLERA VACCINE AGAINST DIARRHEA ASSOCIATED WITH HEAT-LABILE TOXIN PRODUCING ENTERO-TOXIGENIC ESCHERICHIA-COLI - RESULTS OF A LARGE-SCALE FIELD TRIAL
复制标题
DOI:
10.1093/infdis/158.2.372
复制
发表时间:
1988-08-01
影响因子:
6.4
通讯作者:
HOLMGREN, J
中科院分区:
文献类型:
--
作者:
CLEMENS, JD;SACK, DA;HOLMGREN, J
The B subunit (BS) of cholera toxin and that of the heat-labile enterotoxin (LT) of enterotoxigenic Escherichia coli (ETEC) are antigenically similar. We therefore assessed whether a combined cholera toxin BS/whole-cell (BS-WC) oral vaccine against cholera conferred cross-protection against LT-producing ETEC (LT-ETEC) diarrhea in a randomized, double-blind field trial among rural Bangladeshi children and women. The 24,770 persons who ingested two or more doses of BS-WC vaccine were compared with 24,842 controls who took two or more doses of killed whole-cell (WC) oral cholera vaccine. Sixty-seven percent fewer episodes of LT-ETEC diarrhea were noted in the BS-WC group than in the WC group during short-term (three-month) follow-up (P < 0.01), but no reduction was evident during the ensuing nine months. Short-term protection was particularly notable against LT-ETEC diarrhea causing life-threatening dehydration (protective efficacy, 86%; P < 0.05).